DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

31.74 -1.47 (-4.41%)

REAL-TIME: Last trade at

Extended Hours: $31.73 $0.00 (-0.02%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

SGEN $31.74 -4.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.45
Previous Close $33.20
Daily Range $31.69 - $33.45
52-Week Range $30.05 - $55.99
Market Cap $3.9B
P/E Ratio -63.85
Dividend (Yield) $0.00 (0.0%)
Volume 673,795
Average Daily Volume 1,403,731
Current FY EPS -$0.66

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary Rss Feed

Why Seattle Genetics, Inc. Stock Dove 12% in December

Seattle Genetics' shares get hammered following impressive clinical data from its rivals at the American Society of Hematology's annual meeting. Find out whether this dip represents a buying opportunity or a red flag.

Earnings Peek: Market Seems Determined To Keep Seattle Genetics In The $30s

First Week of SGEN September 18th Options Trading

Commit To Buy Seattle Genetics At $25, Earn 8.5% Annualized Using Options

ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF

Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog

Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog

New Biotech ETF From ALPS

Bull of the Day: Incyte (INCY) - Bull of the Day

Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger?

See More SGEN News...

SGEN's Top Competitors

SGEN $31.74 (-4.41%)
Current stock: SGEN
AMGN $154.64 (-2.67%)
Current stock: AMGN
GILD $102.45 (-2.46%)
Current stock: GILD
BIIB $351.18 (-1.87%)
Current stock: BIIB